Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Patients should not adjust or supplement beyond their prescribed regimen without specialist advice
Rotem A, Janzer A, Izar B, Ji Z, Doench JG, Garraway LA, et al
2018;363:k4226
Saxenda (active ingredient: liraglutide) subcutaneous injection Initial FDA Approval: 2014 (liraglutide approved in 2010) Side Effect Update Date: May 28, 2025 Medication Description: For chronic weight management Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting
Yachida, S
Many GLP-1 users do better with small protein anchors across the day instead of one or two large meals that become difficult to finish
US$ 23.13
US$ 26.60
US$ 23.61
US$ 27.97
US$ 25.83
US$ 20.02
US$ 29.13
US$ 27.64
